OrthoPediatrics Corp. announced the launch of a new division, focused on non-surgical intervention for pediatric orthopedics. The OrthoPediatrics Specialty Bracing division (?OPSB?) will serve as a house of brands and innovative products that expand the Company?s Total Addressable Market by approximately $600 million.

The Company first entered the non-operative space through the acquisition of MD Orthopaedics Inc. (MDO) in 2022, and their bracing product lines and the patented Mitchell Ponseti® Ankle-Foot Orthosis (AFO) system for the treatment of clubfoot. Since the transaction, the Company has been aggressively building a portfolio of complementary products to address the large unmet needs for specialty bracing within the pediatric orthopedic market. Earlier this year, MDO acquired the assets of Rhino Pediatric Orthopedic Designs Inc., a San Diego based company founded by two pediatric orthopedic surgeons.

The Rhino? ?Kicker? and ?Cruiser?

braces were designed for children with Developmental Dysplasia of the hip. Additionally, the Company announced the release of the DF2® Brace as part of its expansion in the non-surgical business for treating kids with musculoskeletal injuries. The DF2® Brace is intended for femur fracture fixation in pediatric patients from approximately 6 months to 5 years of age instead of spica cast by providing immobilization of the femur, knee, and hip.

Most recently, the Company announced a new partnership with Montreal-based Ora Medical, to distribute The Levity, a gait-trainer device designed for children with walking difficulties.